US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dianthus Therapeutics Inc.

21.36

+0.91004.45%

Volume:169.62K

Turnover:3.55M

Market Cap:686.19M

PE:-8.37

High:21.37

Open:20.78

Low:20.37

Close:20.45

Loading ...

Overview Company News Filings

Point72 Asset Management, L.p. Reports 5.9% Passive Stake in Dianthus Therapeutics as of April 10 - SEC Filing

THOMSON REUTERS

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?

Dianthus Therapeutics: Promising Growth Potential with Innovative DNTH103 and Strong Financial Position

Dianthus Therapeutics Inc: $357.0 Mln of Cash Provides Runway Into 2H'27

THOMSON REUTERS

Dianthus Therapeutics Inc - Q4 Shr Loss $0.81

THOMSON REUTERS

Dianthus Therapeutics Q4 EPS $(0.81) Beats $(0.85) Estimate, Sales $1.32M Beat $859.70K Estimate

Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results

Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, a Seasoned Commercial Leader, to Board of Directors

THOMSON REUTERS

Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?

Stifel Nicolaus Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)

Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences

Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Dianthus Therapeutics (DNTH) Receives a New Rating from TD Cowen

Dianthus Therapeutics (DNTH) Receives a Buy from Stifel Nicolaus

Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

Stock Track | Dianthus Therapeutics' Stock Soars 7.86% Following Upbeat Q3 Earnings Report

Dianthus Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

THOMSON REUTERS

Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DNTH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DNTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":21.36,"timestamp":1745348084898,"preClose":20.45,"halted":0,"volume":169615,"delay":0,"floatShares":14121888,"shares":32125179,"eps":-2.55056,"marketStatus":"Trading","change":0.91,"latestTime":"04-22 14:54:46 EDT","open":20.78,"high":21.37,"low":20.37,"amount":3549331.9416099996,"amplitude":0.0489,"askPrice":21.38,"askSize":6,"bidPrice":21.29,"bidSize":144,"shortable":3,"etf":0,"ttmEps":-2.55056,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":20.45,"postHourTrading":{"tag":"盘后","latestPrice":20.45,"preClose":20.45,"latestTime":"16:33 EDT","volume":634,"amount":12963.26,"timestamp":1745267610886},"volumeRatio":0.729507,"impliedVol":0.3052,"impliedVolPercentile":0.0455},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","floatShares":14121888,"roa":"-23.01%","roe":"-32.60%","lyrEps":-2.55056,"volumeRatio":0.729507,"shares":32125179,"dividePrice":0,"high":21.37,"amplitude":0.0489,"preClose":20.45,"low":20.37,"week52Low":13.365,"pbRate":"1.95","psRate":"110.06","week52High":32.27,"institutionHeld":0,"latestPrice":21.36,"committee":0.92,"eps":-2.55056,"divideRate":0,"volume":169615,"delay":0,"ttmEps":-2.55056,"open":20.78,"prevYearClose":21.8,"prevWeekClose":19.5,"prevMonthClose":18.14,"prevQuarterClose":18.14,"fiveDayClose":18.71,"twentyDayClose":19.41,"sixtyDayClose":21.21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DNTH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528018773","title":"Point72 Asset Management, L.p. Reports 5.9% Passive Stake in Dianthus Therapeutics as of April 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2528018773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528018773?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:22","pubTimestamp":1744921359,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV3EA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2522774924","title":"Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522774924","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522774924?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:57","pubTimestamp":1742824620,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals  shares soared 11.8% in the last trading session to close at $283.34. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 1% gain over the past four weeks.For Dianthus Therapeutics, Inc. , the consensus EPS estimate for the upcoming report has changed +5.3% over the past month to -$0.86. This represents a change of -59.3% from what the company reported a year ago. Dianthus Therapeutics, Inc. currently has a Zacks Rank of #3 .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alnylam-alny-surges-11-8-135700394.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4139","BK4588","DNTH","ALNY","BK4548"],"gpt_icon":0},{"id":"2518085085","title":"Dianthus Therapeutics: Promising Growth Potential with Innovative DNTH103 and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2518085085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518085085?lang=en_us&edition=fundamental","pubTime":"2025-03-12 09:35","pubTimestamp":1741743316,"startTime":"0","endTime":"0","summary":"Yaron Werber, an analyst from TD Cowen, has initiated a new Buy rating on Dianthus Therapeutics (DNTH). Yaron Werber’s rating is based on several c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/dianthus-therapeutics-promising-growth-potential-with-innovative-dnth103-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/dianthus-therapeutics-promising-growth-potential-with-innovative-dnth103-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","DNTH"],"gpt_icon":0},{"id":"2518677110","title":"Dianthus Therapeutics Inc: $357.0 Mln of Cash Provides Runway Into 2H'27","url":"https://stock-news.laohu8.com/highlight/detail?id=2518677110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518677110?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:13","pubTimestamp":1741723991,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2518577153","title":"Dianthus Therapeutics Inc - Q4 Shr Loss $0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2518577153","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518577153?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:06","pubTimestamp":1741723578,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU147:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2518577903","title":"Dianthus Therapeutics Q4 EPS $(0.81) Beats $(0.85) Estimate, Sales $1.32M Beat $859.70K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518577903","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518577903?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:03","pubTimestamp":1741723408,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.85) by 4.71 percent. This is a 14.08 percent decrease over losses of $(0.71) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44262066/dianthus-therapeutics-q4-eps-0-81-beats-0-85-estimate-sales-1-32m-beat-859-70k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"2518779779","title":"Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518779779","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518779779?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:01","pubTimestamp":1741723260,"startTime":"0","endTime":"0","summary":"Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis  ongoing; top-line results on track for 2H'25. Phase 3 CAPTIVATE trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy  ongoing; interim responder analysis anticipated in 2H'26. Phase 2 MoMeNtum trial of DNTH103 in Multifocal Motor Neuropathy  ongoing;\"We remain on track to report top-line data in 2H'25 from our Phase 2 clinical trial of DNTH103 in gMG, an indication where a best-in-class, potent active C1s and classical pathway inhibitor with the potential for effective and consistent symptom control along with improved safety and convenience could meaningfully advance the standard of care,\" said Marino Garcia, Chief Executive Officer of Dianthus Therapeutics. \"We are excited to have initiated our pivotal Phase 3 CAPTIVATE trial in CIDP, which is on track for an interim responder analysis in 2H'26, along with top-line results from our Phase 2 trial in MMN.\". -- Phase 3 CAPTIVATE CIDP trial ongoing: The CAP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0882574139.USD","LU1363072403.SGD","LU0170899867.USD","LU0149725797.USD","BK4006","IE00BHPRN162.USD","LU0267386448.USD","LU0971096721.USD","CMC","BK4139","DNTH","LENZ","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2517136039","title":"Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, a Seasoned Commercial Leader, to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136039","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517136039?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA8QXZY8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2511301590","title":"Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511301590","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511301590?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:25","pubTimestamp":1739370300,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals  shares rallied 5.2% in the last trading session to close at $129.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.3% gain over the past four weeks.Rising optimism related to the company’s diverse portfolio of marketed drugs, including leading therapies for sleep disorders and epilepsy and a growing portfolio of cancer treatments, might have driven the recent share price rally.This drugmaker is expected to post quarterly earnings of $5.79 per share in its upcoming report, which represents a year-over-year change of +15.3%. Revenues are expected to be $1.06 billion, up 4.8% from the year-ago quarter.For Jazz, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on JAZZ going forward to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-jazz-surges-5-2-142500717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","BK4533","LU0109394709.USD","DNTH","BK4532","BK4139","IE00BN0W2T93.GBP","BK4007","LU0320765992.SGD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","JAZZ"],"gpt_icon":0},{"id":"2510285112","title":"Stifel Nicolaus Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510285112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510285112?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:45","pubTimestamp":1739191543,"startTime":"0","endTime":"0","summary":"In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Dianthus Therapeutics (DNTH – Research Report), with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-dianthus-therapeutics-dnth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-buy-rating-on-dianthus-therapeutics-dnth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","SF"],"gpt_icon":0},{"id":"2507642854","title":"Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2507642854","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507642854?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:00","pubTimestamp":1738238400,"startTime":"0","endTime":"0","summary":"NEW YORK and WALTHAM, Mass., Jan. 30, 2025  -- Dianthus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation and presentations by Marino Garcia, Chief Executive Officer, at the following healthcare investor conferences during the month of February:. Guggenheim SMID Cap Biotech Conference – Fireside chat on February 6 at 9:00 a.m. ET in New York City. Oppenheimer 35th Annual Healthcare Life Sciences Conference – Fireside chat on February 12 at 3:20 p.m. ET, taking place virtually. Live webcasts of the Company’s presentations may be accessed under “News and Events” in the Investorssection of the Dianthus Therapeutics website.To learn more, please visit www.dianthustx.com and follow us on LinkedIn.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dianthus-therapeutics-webcast-presentations-two-120000426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","DNTH","LENZ"],"gpt_icon":0},{"id":"2501066723","title":"Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2501066723","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501066723?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:00","pubTimestamp":1736337600,"startTime":"0","endTime":"0","summary":"NEW YORK and WALTHAM, Mass., Jan. 08, 2025  -- Dianthus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation at the 43rd Annual J.P. Morgan Healthcare Conference. Marino Garcia, Chief Executive Officer, will present a corporate overview on Wednesday, January 15, 2025 at 9:00 a.m. PST / 12:00 p.m. EST in San Francisco.A live webcast of the Company’s presentation may be accessed under “News and Events” in the Investorssection of the Dianthus Therapeutics website.To learn more, please visit www.dianthustx.com and follow us on LinkedIn.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dianthus-therapeutics-webcast-presentation-43rd-120000700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4504","BK4516","BK4139","BK4534","LU1668664300.SGD","BK4127","LU0006306889.USD","LU0314104364.USD","LU1720051108.HKD","BK4585","LU0267386448.USD","LU0098860793.USD","LU1732800096.USD","LU2089283258.USD","LU1363072403.SGD","LU1720051017.SGD","LU2357305700.SGD","LU1074936037.SGD","HCSG","LU1989772840.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU2111349929.HKD","LU0795875086.SGD","LU1162221912.USD","LU0158827948.USD","LU2089284900.SGD","LU0320765646.SGD","IE00BKVL7J92.USD","LU0106261372.USD","LU2028103732.USD","LU0158827781.USD","BK4588","BK4137","DNTH","LU0912757837.SGD","LU2023251221.USD","LU1548497426.USD","LU1989772923.USD","LU1732799900.SGD","LU2271345857.HKD","LU2347655156.SGD","LU0795875169.SGD","LU0225283273.USD","BK4581","LU0106831901.USD"],"gpt_icon":0},{"id":"2493427582","title":"Dianthus Therapeutics (DNTH) Receives a New Rating from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2493427582","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493427582?lang=en_us&edition=fundamental","pubTime":"2024-12-21 02:21","pubTimestamp":1734718919,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics (DNTH – Research Report) received a Buy rating and price target from TD Cowen analyst Yaron Werber today. The company’s share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-new-rating-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-new-rating-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","TD","COWN"],"gpt_icon":0},{"id":"2492677994","title":"Dianthus Therapeutics (DNTH) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2492677994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492677994?lang=en_us&edition=fundamental","pubTime":"2024-12-17 10:05","pubTimestamp":1734401143,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Dianthus Therapeutics (DNTH – Research Report), w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4127","DNTH","BK4139","CFA"],"gpt_icon":0},{"id":"2482665542","title":"Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2482665542","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482665542?lang=en_us&edition=fundamental","pubTime":"2024-11-10 21:05","pubTimestamp":1731243943,"startTime":"0","endTime":"0","summary":"NasdaqCM:DNTH Earnings and Revenue Growth November 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates significantly. Earnings per share  missed analyst estimates by 23%.Looking ahead, revenue is forecast to grow 59% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are up 3.7% from a week ago.Be aware that  Dianthus Therapeutics is showing  3 warning signs in our investment analysis and 2 of those are potentially serious...","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dianthus-therapeutics-third-quarter-2024-130543172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"1146937123","title":"Stock Track | Dianthus Therapeutics' Stock Soars 7.86% Following Upbeat Q3 Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1146937123","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146937123?lang=en_us&edition=fundamental","pubTime":"2024-11-08 22:33","pubTimestamp":1731076389,"startTime":"0","endTime":"0","summary":"Shares of Dianthus Therapeutics Inc.  surged 7.86% on Thursday morning, following the company's third-quarter earnings report that beat analysts' expectations on the revenue front.The biotechnology firm reported a quarterly adjusted loss of $0.72 per share, wider than the expected loss of $0.59 per share. However, revenue rose a staggering 135.1% year-over-year to $2.17 million, significantly higher than the consensus estimate of $648,500.Despite the larger-than-expected loss, investors seemed t","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Dianthus Therapeutics' Stock Soars 7.86% Following Upbeat Q3 Earnings Report","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DNTH"],"gpt_icon":0},{"id":"2481620190","title":"Dianthus Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481620190","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481620190?lang=en_us&edition=fundamental","pubTime":"2024-11-08 12:59","pubTimestamp":1731041983,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary  Dianthus Therapeutics Inc DNTH.OQ reported a quarterly adjusted loss of 72 cents per share for the q","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF0DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH"],"gpt_icon":0},{"id":"2481507151","title":"Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481507151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481507151?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:01","pubTimestamp":1731013263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUAC9LMPG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2480420301","title":"Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2480420301","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480420301?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":"NEW YORK and WALTHAM, Mass., Nov. 04, 2024  -- Dianthus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation and corporate overview presentations by Marino Garcia, Chief Executive Officer, at the following healthcare investor conferences during November and December 2024:. Guggenheim Healthcare Innovation Conference on November 11 at 1:30 p.m. ET in Boston, MA. Jefferies Global Healthcare Conference on November 19 at 9:00 a.m. GMT in London. 7th Annual Evercore HealthCONx Conference on December 4 at 10:50 a.m. ET in Coral Gables, FL. Live webcasts of the Company’s presentations at these three conferences may be accessed under “News and Events” in the Investorssection of the Dianthus Therapeutics website.To learn more, please visit www.dianthustx.com and follow us on LinkedIn.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dAM_eMt8TpnD9GyVPtPvUg--~B/aD01ODA7dz0zMDY4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dAM_eMt8TpnD9GyVPtPvUg--~B/aD01ODA7dz0zMDY4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dianthus-therapeutics-participate-three-upcoming-120000255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","HCSG","BK4137","DNTH"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DNTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-11","symbol":"DNTH","fiscalQuarterEnding":"2024/12","expectedEps":-0.85,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2024-11-07","symbol":"DNTH","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2024-08-08","symbol":"DNTH","fiscalQuarterEnding":"2024/06","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2024-05-09","symbol":"DNTH","fiscalQuarterEnding":"2024/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-03-21","symbol":"DNTH","fiscalQuarterEnding":"2023/12","expectedEps":-1.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"post","actualEps":-0.71}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DNTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DNTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":12,"updateTime":1734926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DNTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DNTH","date":"2025-04-21","current":-7.372583,"percent":0.72043,"low":-21.520733,"twenty":-15.403915,"median":-11.244659,"eighty":-5.610226,"high":-2.378652,"avg":-11.151766,"sd":4.673657,"marketCap":626440990},"quantilePoints":[{"date":"2023-09-22","current":-6.821887,"twenty":-6.869759,"median":-6.842701,"eighty":-6.807317,"marketCap":194260047},{"date":"2023-09-29","current":-5.576152,"twenty":-6.838538,"median":-5.576152,"eighty":-5.435929,"marketCap":201460812},{"date":"2023-10-06","current":-4.920135,"twenty":-6.800032,"median":-5.4757,"eighty":-5.354747,"marketCap":177759540},{"date":"2023-10-13","current":-4.916034,"twenty":-6.077097,"median":-5.403948,"eighty":-4.942276,"marketCap":177611407},{"date":"2023-10-20","current":-5.11694,"twenty":-5.587632,"median":-5.309646,"eighty":-5.016077,"marketCap":184869921},{"date":"2023-10-27","current":-4.75613,"twenty":-5.576152,"median":-5.262494,"eighty":-4.957036,"marketCap":171834222},{"date":"2023-11-03","current":-4.920135,"twenty":-5.49415,"median":-5.12514,"eighty":-4.920135,"marketCap":177759540},{"date":"2023-11-10","current":-4.678228,"twenty":-5.457249,"median":-5.084139,"eighty":-4.879133,"marketCap":169019695},{"date":"2023-11-17","current":-3.935775,"twenty":-5.444949,"median":-4.957036,"eighty":-4.76023,"marketCap":169663374},{"date":"2023-11-24","current":-4.021709,"twenty":-5.412148,"median":-4.920135,"eighty":-4.674948,"marketCap":173367815},{"date":"2023-12-01","current":-3.842966,"twenty":-5.377707,"median":-4.920135,"eighty":-3.993522,"marketCap":165662579},{"date":"2023-12-08","current":-3.640162,"twenty":-5.338346,"median":-4.907834,"eighty":-3.949524,"marketCap":156920099},{"date":"2023-12-15","current":-2.684576,"twenty":-5.297345,"median":-4.846332,"eighty":-3.884902,"marketCap":115726721},{"date":"2023-12-22","current":-3.007688,"twenty":-5.267824,"median":-4.788931,"eighty":-3.85534,"marketCap":129655417},{"date":"2023-12-29","current":-3.482043,"twenty":-5.235843,"median":-4.75818,"eighty":-3.842966,"marketCap":150103929},{"date":"2024-01-05","current":-4.482315,"twenty":-5.235843,"median":-4.715129,"eighty":-3.861528,"marketCap":193223616},{"date":"2024-01-12","current":-4.05952,"twenty":-5.169421,"median":-4.670027,"eighty":-3.873902,"marketCap":174997769},{"date":"2024-01-19","current":-3.952961,"twenty":-5.12186,"median":-4.521845,"eighty":-3.879402,"marketCap":170404263},{"date":"2024-01-26","current":-6.135656,"twenty":-5.267824,"median":-4.661827,"eighty":-3.893152,"marketCap":264495873},{"date":"2024-02-02","current":-14.091886,"twenty":-5.428549,"median":-4.735629,"eighty":-3.901401,"marketCap":607473021},{"date":"2024-02-09","current":-15.77856,"twenty":-5.593373,"median":-4.788931,"eighty":-3.913775,"marketCap":680182147},{"date":"2024-02-16","current":-16.247836,"twenty":-6.141843,"median":-4.875033,"eighty":-3.933712,"marketCap":700411702},{"date":"2024-02-23","current":-16.322648,"twenty":-6.585949,"median":-4.911934,"eighty":-3.935775,"marketCap":703636704},{"date":"2024-03-01","current":-16.832731,"twenty":-6.855189,"median":-4.920135,"eighty":-3.939212,"marketCap":725625351},{"date":"2024-03-08","current":-17.220393,"twenty":-14.108208,"median":-4.920135,"eighty":-3.952961,"marketCap":742336722},{"date":"2024-03-15","current":-18.274564,"twenty":-15.869694,"median":-5.055438,"eighty":-3.952961,"marketCap":787779926},{"date":"2024-03-22","current":-19.002283,"twenty":-16.27504,"median":-5.103895,"eighty":-3.958461,"marketCap":819150396},{"date":"2024-03-28","current":-20.617859,"twenty":-16.390659,"median":-5.12104,"eighty":-3.98046,"marketCap":898010856},{"date":"2024-04-05","current":-16.662734,"twenty":-16.662734,"median":-5.235843,"eighty":-3.987335,"marketCap":725745374},{"date":"2024-04-12","current":-16.777278,"twenty":-16.777278,"median":-5.350646,"eighty":-3.990772,"marketCap":730734324},{"date":"2024-04-19","current":-15.922581,"twenty":-16.832731,"median":-5.444949,"eighty":-3.99421,"marketCap":693508032},{"date":"2024-04-26","current":-14.143673,"twenty":-16.777278,"median":-5.535151,"eighty":-4.021709,"marketCap":616027659},{"date":"2024-05-03","current":-16.178636,"twenty":-16.662734,"median":-5.637242,"eighty":-4.021709,"marketCap":704660510},{"date":"2024-05-10","current":-14.570862,"twenty":-16.662734,"median":-6.140812,"eighty":-4.049207,"marketCap":731661246},{"date":"2024-05-17","current":-15.342363,"twenty":-16.621896,"median":-6.530951,"eighty":-4.05952,"marketCap":770401432},{"date":"2024-05-24","current":-12.724299,"twenty":-16.45867,"median":-6.737265,"eighty":-4.100768,"marketCap":638937940},{"date":"2024-05-31","current":-12.098897,"twenty":-16.404261,"median":-6.842701,"eighty":-4.106268,"marketCap":607534008},{"date":"2024-06-07","current":-12.233329,"twenty":-16.390659,"median":-12.098897,"eighty":-4.121392,"marketCap":614284386},{"date":"2024-06-14","current":-15.75779,"twenty":-16.354335,"median":-12.233329,"eighty":-4.176389,"marketCap":791261684},{"date":"2024-06-21","current":-15.114854,"twenty":-16.327131,"median":-12.630781,"eighty":-4.296009,"marketCap":758977268},{"date":"2024-06-28","current":-14.565435,"twenty":-16.324142,"median":-12.706764,"eighty":-4.381256,"marketCap":731388767},{"date":"2024-07-05","current":-15.459702,"twenty":-16.325636,"median":-12.794437,"eighty":-4.452753,"marketCap":776293455},{"date":"2024-07-12","current":-16.932611,"twenty":-16.417863,"median":-13.066224,"eighty":-4.47819,"marketCap":850254116},{"date":"2024-07-15","current":-16.920921,"twenty":-16.466954,"median":-13.180199,"eighty":-4.480252,"marketCap":849667127},{"date":"2024-08-02","current":-16.371502,"twenty":-16.45867,"median":-13.180199,"eighty":-4.482315,"marketCap":822078626},{"date":"2024-08-09","current":-13.845994,"twenty":-16.50009,"median":-13.738229,"eighty":-4.561374,"marketCap":784804801},{"date":"2024-08-16","current":-15.438194,"twenty":-16.45867,"median":-13.792112,"eighty":-4.661827,"marketCap":875052279},{"date":"2024-08-23","current":-14.304023,"twenty":-16.390659,"median":-14.112289,"eighty":-4.678228,"marketCap":810766318},{"date":"2024-08-30","current":-14.899592,"twenty":-16.390659,"median":-14.219338,"eighty":-4.715129,"marketCap":844523786},{"date":"2024-09-06","current":-14.490462,"twenty":-16.375333,"median":-14.311791,"eighty":-4.74793,"marketCap":821333873},{"date":"2024-09-13","current":-14.402421,"twenty":-16.338396,"median":-14.319559,"eighty":-4.75941,"marketCap":816343639},{"date":"2024-09-20","current":-14.552608,"twenty":-16.324142,"median":-14.311791,"eighty":-4.783191,"marketCap":824856392},{"date":"2024-09-27","current":-13.993291,"twenty":-16.306326,"median":-14.304023,"eighty":-4.815172,"marketCap":793153726},{"date":"2024-10-04","current":-14.221161,"twenty":-16.285922,"median":-14.291076,"eighty":-4.861093,"marketCap":806069627},{"date":"2024-10-11","current":-14.672555,"twenty":-16.269355,"median":-14.319559,"eighty":-4.877493,"marketCap":831655088},{"date":"2024-10-18","current":-14.522306,"twenty":-16.254626,"median":-14.311791,"eighty":-4.902094,"marketCap":823138846},{"date":"2024-10-25","current":-14.475677,"twenty":-16.248614,"median":-14.360865,"eighty":-4.914394,"marketCap":820495874},{"date":"2024-10-31","current":-14.486039,"twenty":-16.239675,"median":-14.366036,"eighty":-4.918495,"marketCap":821083201},{"date":"2024-11-08","current":-13.087312,"twenty":-16.213004,"median":-14.381745,"eighty":-4.920135,"marketCap":878053924},{"date":"2024-11-15","current":-11.244659,"twenty":-16.189942,"median":-14.360865,"eighty":-4.920135,"marketCap":754426637},{"date":"2024-11-22","current":-8.941908,"twenty":-16.180782,"median":-14.311791,"eighty":-4.920135,"marketCap":599930480},{"date":"2024-11-29","current":-10.582949,"twenty":-16.17095,"median":-14.273283,"eighty":-4.920135,"marketCap":710031190},{"date":"2024-12-06","current":-10.437372,"twenty":-16.142849,"median":-14.241876,"eighty":-4.934895,"marketCap":700264191},{"date":"2024-12-13","current":-10.36679,"twenty":-16.097823,"median":-14.188265,"eighty":-4.996397,"marketCap":695528677},{"date":"2024-12-20","current":-10.163866,"twenty":-16.05809,"median":-14.112289,"eighty":-5.061998,"marketCap":681914073},{"date":"2024-12-27","current":-10.14622,"twenty":-16.019613,"median":-14.091886,"eighty":-5.076759,"marketCap":680730195},{"date":"2025-01-03","current":-10.234448,"twenty":-15.922581,"median":-13.957579,"eighty":-5.096439,"marketCap":686649588},{"date":"2025-01-10","current":-11.284361,"twenty":-15.89482,"median":-13.822388,"eighty":-5.108369,"marketCap":757090364},{"date":"2025-01-17","current":-8.474299,"twenty":-15.887478,"median":-13.728741,"eighty":-5.115822,"marketCap":568557697},{"date":"2025-01-24","current":-9.828599,"twenty":-15.834329,"median":-13.708453,"eighty":-5.12186,"marketCap":659420380},{"date":"2025-01-31","current":-9.603618,"twenty":-15.788231,"median":-13.553088,"eighty":-5.191562,"marketCap":644325928},{"date":"2025-02-07","current":-10.128574,"twenty":-15.779567,"median":-13.462457,"eighty":-5.235843,"marketCap":679546316},{"date":"2025-02-14","current":-10.644708,"twenty":-15.766098,"median":-13.180199,"eighty":-5.267824,"marketCap":714174765},{"date":"2025-02-21","current":-10.455018,"twenty":-15.745542,"median":-13.087312,"eighty":-5.305545,"marketCap":701448070},{"date":"2025-02-28","current":-9.285997,"twenty":-15.702913,"median":-12.81575,"eighty":-5.346546,"marketCap":623016113},{"date":"2025-03-07","current":-10.375613,"twenty":-15.663831,"median":-12.724299,"eighty":-5.384267,"marketCap":696120616},{"date":"2025-03-14","current":-8.045567,"twenty":-15.60664,"median":-12.588406,"eighty":-5.420348,"marketCap":683623809},{"date":"2025-03-21","current":-7.727979,"twenty":-15.500032,"median":-12.233329,"eighty":-5.449869,"marketCap":656638658},{"date":"2025-03-28","current":-7.512473,"twenty":-15.459702,"median":-12.013661,"eighty":-5.472009,"marketCap":638327306},{"date":"2025-04-04","current":-6.416037,"twenty":-15.451099,"median":-11.624039,"eighty":-5.526951,"marketCap":545164287},{"date":"2025-04-11","current":-5.898066,"twenty":-15.431979,"median":-11.290978,"eighty":-5.587632,"marketCap":501152792},{"date":"2025-04-17","current":-7.175981,"twenty":-15.413286,"median":-11.262304,"eighty":-5.60754,"marketCap":609735897},{"date":"2025-04-21","current":-7.372583,"twenty":-15.403915,"median":-11.244659,"eighty":-5.610226,"marketCap":626440990}],"updateTime":1745343584535}}}